In vitro Evaluation of Trimethoprim and Sulfamethoxazole from Fixed-Dose Combination Generic Drugs using Spectrophotometry: Comparison of Flow-Through Cell and USP Paddle Methods

Purpose: To develop a first-order derivative spectrophotometric method for the determination of trimethoprim (TMP) and sulfamethoxazole (SMX) from fixed-dose combination generic products using a flow-through cell technique.Methods: Absorbance measurement was achieved at 247.8 and 257.9 nm for trimethoprim and sulfamethoxazole, respectively. USP Apparatus 4 with 22.6 mm cells, laminar flow at 16 ml/min, and 0.1 N HCl at 37 °C as dissolution medium, were used. Dissolution profiles were compared with modeldependent and independent methods.Results: All the products met the pharmacopeial dissolution criterion (Q ≥ 70 %, at 60 min), except SMX in two products (SC 400 mg and SB1 800 mg) using the flow-through cell (53.62 and 49.74 % dissolved, respectively). Using both USP apparatuses, significant differences in mean dissolution time and dissolution efficiency values were found (p < 0.05). All products were in line with Weibull’s kinetics and significant differences in derived parameters (Td) values were found (p < 0.05).Conclusion: Determination of TMP and SMX by derivative spectrophotometry can easily be employed for dissolution studies using the flow-through cell technique. However, it would be necessary to determine correlation with in-vivo test results in order to assure safe interchangeability.Keywords: Trimethoprim, Sulfamethoxazole, Flow-through cell method, First-order derivative spectrophotometry, Fixed-dose combination generic drug